The widespread availability of an FDA-approved vaccine for COVID-19 will not ensure its consumption by the public. This is reflective of a broad cultural problem there is a deep undercurrent of mistrust, especially of elites, running through American society today but it also echoes a cultural problem in the world of science, specifically.
Americans of all stripes have come to regard scientists as part of the elite, in part because they have sequestered themselves in an ivory tower, saturated with ambition for academic honors and consumed with sterile intellectual gymnastics. Much of current scientific culture focuses on nuances whose sole purpose is to garner their researchers higher academic status by impressing colleagues, rather than serving the public's interest or carrying any practical relevance for our daily life.
This state of affairs is particularly apparent in my field: the world of physics. For instance, in theoretical physics, a phalanx of untestable notionsabout the multiverse, hypothesized extra dimensions, the idea that we live in a simulation, and the argument that there is no need for experimental evidence to justify the string theory strategy in unifying quantum mechanics and gravityoccupy centerstage. At the same time, there is a taboo on an open discussion of certain common-sense questions, such as whether there are other intelligent civilizations in outer space and whether our civilization is the smartest kid on the galactic block.
"The surest way to corrupt a youth is to instruct him to hold in higher esteem those who think alike than those who think differently", wrote the philosopher Friedrich Nietzsche in his book "The Dawn of Day," published in 1881. And indeed, the psychological pressure on physicists to conform with fashionable trends promotes a herd mentality in which young scientists today feel obligated to work on far-fetched ideas promoted by senior colleagues just in order to secure jobs, thereby perpetuating the problem. These young scientists learn from the examples set by their elders, who often react to original thought with violent pushback and bullying. I know, because I have been the subject of such assaults.
When the first interstellar object, 'Oumuamua, was glimpsed passing through our solar system in October of 2017, scientists quickly agreed that it was weird on half-a-dozen counts: it had a flattened shape with extreme proportions never seen before among comets or asteroids, an unusual initial velocity, and a shiny appearance; it lacked a cometary tail, but nevertheless it exhibited a push away from the Sun not explainable by gravity. However, despite these anomalies, the mainstream scientific community immediately declared business as usual and decreed the object to have been an unusual asteroid or cometalbeit one that was unlike any asteroid or comet seen before. The response brought to mind a kid who has encountered many cats at home and, upon visiting the zoo and seeing an elephant, simply assumes it to be an unusual cat. Such naivete is charming in a child; it is less tolerable in a scientist.
We ought to hold ourselves to a higher standard, I felt so several months after 'Oumuamua was first sighted, I suggested that its weirdness may imply that it was a product of an alien technology, possibly a thin sail pushed by sunlight. (Our own civilization has dreamed of such a perfect spacefaring technology for decades, and I had recently helped to design a prototype of one for the Breakthrough Starshot Initiative, an effortsupported by earthbound innovators and dreamers such as Yuri Milnerto reach our closest neighboring star within our lifetimes.)
In fact, another object showing evidence for push by sunlight with no cometary tail was discovered in September 2020 by Pan STARRS. It was initially given an astronomical label, 2020 SO, before it was identified as a stray rocket booster from a 1966 mission to the Moon that is still bound to the Sun. 'Oumuamua moved much fasteron an escaping trajectory from the Sun, implying that it must have originated from interstellar space.
When I spend time on vacation near a beach, I enjoy studying natural seashells but every so often I encounter a plastic bottle which is artificially made. Whatever its purpose, if artificial in origin, 'Oumuamua would represent "a message in a bottle": the first evidence that we are not alone.
I first articulated this hypothesis in a commentary that I published in Scientific American; I subsequently quantified it in a scientific paper with my postdoc, Shmuel Bialy. Although far from the most speculative thing I have ever published indeed, in comparison to some of my research on dark matter, the paper was rather tame it generated quite a fuss. It was accepted for publication within a few days of its submission to The Astrophysical Journal Letters. It became the only paper I know of to have been quoted verbatim on both CNN and Fox News, and to have inspired a new brand of wine ("Cuve 'Oumuamua" by Bonny Doon). And judging by my inbox, it has stirred a great deal of interest in people far beyond the rarefied halls of academia.
But my idea also generated an impulsive pushback within the scientific mainstream. Some scientists expressed a strong opinion on Twitter based on prejudice without studying the evidence. It would have been better if they had followed the advice of basketball coaches: "keep your eyes on the ball and not the audience". After all, by siding with the mainstream during Galileo Galillei's days, we wouldhave given justification to placing him in house arrest rather than looking through his telescope. This would clearly be in contradiction to our current support of evidence-based science.Reality does not go away if you ignore it.
At the same time that conservative scientists argue for "business as usual" regarding 'Oumuamua, other reputable scientists admit that the object is weird and suggest "never seen before" explanations for it each of which requires an imaginative leap much greater than the one necessitated by the lightsail hypothesis. For example, a recent suggestion was that 'Oumuamua may be a hydrogen iceberg, but this explanation faces the problem that such an object is likely to evaporate during its long interstellar journey. Another recent proposal, that it is an elongated fragment from the gravitational disruption of a bigger object by a star, faces the shortcoming that such disruptions are rare and that 'Oumuamua's shape was inferred to be pancake-like based on its light curve. Another suggestion, that 'Oumuamua is pushed by sunlight because it is a porous dust bunny which is a hundred times less dense than air, raises severe doubts about its ability to survive through a tumultuous interstellar trip for millions of years.
The mainstream orthodoxy contradicts itself by claiming that 'Oumuamua is not unusual and at the same time endorsing these notions that it could be explained by "never-seen-before" natural mechanisms. One cannot escape the impression that these exotic explanations are promoted simply to avoid a discussion on the possibility that 'Oumuamua might be of artificial origin.
Why is the study of alternative explanations for the anomalies of 'Oumuamua any different from the search for radical explanations for possible anomalies (involving cores instead of cusps in the centers of galaxies or unusually cold hydrogen during the cosmic dark ages) tied to the unknown nature of the dark matter? Given that between a quarter and half of all stars we examined host an Earth-like planet with a surface temperature that can support liquid water and the chemistry of life-as-we-know-it, the proposition that we are not alone is rather conservative, and should have been endorsed by the mainstream by now. Yet our scientistsand our elected leaderswould prefer not to look under this particular rock. In 1993, Congress halted federal funding to the Search for Extraterrestrial Intelligence (SETI), even though only a tiny fraction of all possible technological signatures of extraterrestrial civilizations had been searched for at that point. Territories that remain unexplored today include industrial pollution of planetary atmospheres, artificial lights, solar cells or mega-structures in space.
It seems obvious to me that space archaeology a burgeoning field of research concerned with the search for extraterrestrial technological relics should be funded as generously as the search for, say, the faddish Weakly Interacting Massive Particles (WIMPs), which were thought to be the constituents of dark matter. The physicists Guiseppe Cocconi and Philips Morrison wrote of SETI in 1959: "The probability for success is difficult to estimate, but if we never search, the chance of success is zero."To that I would add: when you are not ready to find exceptional things, you will never discover them.
Yet my colleagues at the forefront of the search for extraterrestrial intelligence seem to have forgotten this fundamental scientific principle. In contrast to its cool reception in the scientific community, SETI hits a nerve in the general public. There lies a paradox: the public pays taxes that support science and is more eager to know the answer to the question: "are we alone?" than: "are WIMPs the dark matter?", not to speak about supporting speculative notions of "extra dimensions" or the "multiverse", which have no reality check to their credit.
Ironically, indeed, the reason that physicists enjoy freedom is that their blue-sky mainstream used had practical impact. The stable funding of physics stemmed from Vannevar Bush's vision of "The Endless Frontier" after the demonstrated relevance of the Manhattan Project to society. Why would the mainstream scientific community shy away from the public's interests and focus on esoteric questions that have little relevance to the layperson? Are scientists supposed to hide behind the opaque technical walls of a self-sustained bubble and ignore the public that funds their research?
Previous generations of physicists understood that when evidence is incomplete, we have to live with scientific uncertainty and consider multiple interpretations of the available data. I fear that physicists today, like their oft-disparaged counterparts in the SETI community, have forgotten this important principle. Nowhere in science is this failure clearer, in my opinion, than in the scientific community's response to the half-dozen anomalies displayed by the first interstellar object that we have discovered.
A scientist must go where the evidence isbut too often, our scientists do not. I do have hope for the future, however. My optimism stems from raising my young daughters, who have no inhibitions in exploring the truth; this is why they learned so much over the short term of their childhood. Perhaps scientists should behave more like kids. Mistakes are an inevitable part of our learning experience as students of mother nature, humbled by the fact that its splendor often exceeds our imagination.
I am practicing what I preach by preparing to confront my own mistakes. Starting in 2023 the Legacy Survey of Space and Time (LSST) on the Vera C. Rubin Observatory will survey the sky for new objects. If we find another weird object like 'Oumuamua on its way towards us, we could send a spacecraft to take a close-up photo of it and identify its nature. Let my hypothesis about 'Oumuamua be judged according to the evidence from this research, rather than by the popularity contest that guides so much of modern science.
Science is a never-ending work in progress. We show integrity by entertaining multiple possible interpretations of evidence to the public. The new generation of innovators should not be held hostage by the mistakes of the past. After standing in line at the bank, I never hear the cashier saying that I am not allowed to cash my check because the customer ahead of me had an overdraft. We should examine each case based on its own merit.
Scientists could regain the public's trust by being straightforward about the inevitable roller-coaster of trial and error associated with innovation whether it be the search for a vaccine for COVID-19 or the search for technological signatures of other civilizations. Rather than pretending to know the outcome in advance, we should admit what we do not know and study all possible interpretations, so that the public will believe our robust conclusions when new evidence brings clarity.
On December 18, 2020, The Guardian published a report about a tantalizing radio signal that was detected within the Breakthrough Listen project by the Parkes telescope in Australia from the nearest star to the Sun, Proxima Centauri. This dwarf star hosts an Earth-size planet, Proxima b, in its habitable zone where liquid water could allow the chemistry of life on the planet's surface. There is no scientific paper accompanying the report and therefore it's too early to draw any inferences. Astronomers must verify that the signal cannot originate from radio interference on Earth or some natural emission mechanism. Terrestrial interference should be different for telescopes at different locations on Earth. If the radio source repeats and resides on Proxima b, then it should show an 11 days modulation associated with the planet's orbital (and spin) period. As soon as I saw the news report, I wrote to the publisher of my forthcoming book: "We might have friends out there. Better than a five star review is getting reassurance for the book's content from an actual star in the sky".
View post:
From astronomy to immunology, it's time to restore confidence in evidence-based science - Salon
- Scipher Medicine and Atropos Health Partner to Accelerate Precision Medicine and Expand the Immunology Multimodal Network - Business Wire - December 23rd, 2024 [December 23rd, 2024]
- AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition - PMLiVE - December 23rd, 2024 [December 23rd, 2024]
- Sir Gustav Nossal Professor of Immunology to honour giant of Australian science - Walter and Eliza Hall Institute of Medical Research - December 9th, 2024 [December 9th, 2024]
- Research Assistant in Immunology - Surrey, United Kingdom job with UNIVERSITY OF SURREY | 384335 - Times Higher Education - November 28th, 2024 [November 28th, 2024]
- Reflecting on Pioneering organoids and 3D cell cultures for animal and human health - British Society for Immunology | - November 28th, 2024 [November 28th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET - Business Wire - November 20th, 2024 [November 20th, 2024]
- TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development - Business Wire - November 20th, 2024 [November 20th, 2024]
- Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough - Infection Control Today - November 20th, 2024 [November 20th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 - The Bakersfield Californian - November 20th, 2024 [November 20th, 2024]
- Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of... - November 20th, 2024 [November 20th, 2024]
- What it's like in allergy and immunology: Shadowing Dr. Fraser - American Medical Association - November 12th, 2024 [November 12th, 2024]
- Dr. Naba Sharif Elected President of the New Jersey Allergy Asthma and Immunology Society - Newswire - November 12th, 2024 [November 12th, 2024]
- Department of Microbiology and Immunology Named a National Milestones Program - Stony Brook News - October 26th, 2024 [October 26th, 2024]
- Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - businesswire.com - October 26th, 2024 [October 26th, 2024]
- Remembering immunology educator, researcher Tom McDonald, PhD - University of Nebraska Medical Center - October 13th, 2024 [October 13th, 2024]
- Systems immunology approaches to study T cells in health and disease - Nature.com - October 13th, 2024 [October 13th, 2024]
- Leading the charge to discover answers in immunology - The University of Arizona - October 2nd, 2024 [October 2nd, 2024]
- New mouse models offer valuable window into COVID-19 infection - La Jolla Institute for Immunology - October 2nd, 2024 [October 2nd, 2024]
- Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira - Morningstar - October 2nd, 2024 [October 2nd, 2024]
- Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss - FiercePharma - September 23rd, 2024 [September 23rd, 2024]
- Huang Named Head Of Pathology And Immunology - Mirage News - September 15th, 2024 [September 15th, 2024]
- Huang named head of pathology & immunology - Washington University School of Medicine in St. Louis - September 15th, 2024 [September 15th, 2024]
- Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance - September 15th, 2024 [September 15th, 2024]
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan - September 15th, 2024 [September 15th, 2024]
- UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy - UCLA Newsroom - September 2nd, 2024 [September 2nd, 2024]
- Boosting vaccines for the elderly with 'hyperactivators' - Boston Children's Answers - Boston Children's Discoveries - June 27th, 2024 [June 27th, 2024]
- Immunologists Want You to Know These Dust Mite Allergy Facts - Yahoo Lifestyle UK - June 27th, 2024 [June 27th, 2024]
- How Ragon Institute's new building aids its mission Harvard Gazette - Harvard Gazette - June 27th, 2024 [June 27th, 2024]
- Insights into CRS and NPs: Visual and Bibliometric Analysis - Physician's Weekly - June 27th, 2024 [June 27th, 2024]
- Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio - STAT - May 24th, 2024 [May 24th, 2024]
- Biogen Buys Desired Growth In Immunology With $1.15bn Hi-Bio Deal - Scrip - May 24th, 2024 [May 24th, 2024]
- Biogen Boosts Immunology Portfolio with $1.8 Billion Acquisition of HI-Bio - BioPharm International - May 24th, 2024 [May 24th, 2024]
- Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Yahoo Finance - May 24th, 2024 [May 24th, 2024]
- Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition - PMLiVE - May 24th, 2024 [May 24th, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B - MM+M Online - May 24th, 2024 [May 24th, 2024]
- COVID-19 Re-Vaccinations Elicit Neutralizing Antibodies Against Future Variants - Technology Networks - May 24th, 2024 [May 24th, 2024]
- HIV Vaccine Candidate Induces Broadly Neutralizing Antibodies in Humans - Technology Networks - May 24th, 2024 [May 24th, 2024]
- Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Cear - Fiocruz - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal - Marketscreener.com - May 24th, 2024 [May 24th, 2024]
- Fellow Focus in Four: Marat Kribis, MD, Rheumatology, Allergy and Immunology - Yale School of Medicine - April 15th, 2024 [April 15th, 2024]
- Long COVID Can Now Be Detected in the Blood - Technology Networks - April 15th, 2024 [April 15th, 2024]
- Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists ... - La Jolla Institute for Immunology - March 29th, 2024 [March 29th, 2024]
- Seeking new horizons: Where innovators find opportunities in a fast-changing immunology landscape - IQVIA - March 29th, 2024 [March 29th, 2024]
- Researchers identify new way to inhibit immune cells that drive allergic asthma - EurekAlert - March 29th, 2024 [March 29th, 2024]
- Innovation in Oncology and Cancer Immunology Research - Boehringer Ingelheim - March 29th, 2024 [March 29th, 2024]
- Measles outbreaks show the risk of under-vaccination | News | Harvard T.H. Chan School of Public Health - HSPH News - March 29th, 2024 [March 29th, 2024]
- Immunology-oncology ELISA Kits Market to Witness a Healthy Growth by 2030 - WhaTech - March 29th, 2024 [March 29th, 2024]
- Spring Allergy Season Is Getting Worse. Here's What to Know. - The New York Times - March 29th, 2024 [March 29th, 2024]
- Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - STAT - March 29th, 2024 [March 29th, 2024]
- Researchers identify viable vaccine targets for hepatitis C infections - News-Medical.Net - March 29th, 2024 [March 29th, 2024]
- Three research projects awarded funding from the Immunology Institute Pilot Project program - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE - Scrip - February 29th, 2024 [February 29th, 2024]
- AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ... - PR Newswire - February 29th, 2024 [February 29th, 2024]
- Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system - Nature.com - February 29th, 2024 [February 29th, 2024]
- Renowned immunologist and four-decade UAB researcher Max Cooper, M.D., will deliver this year's Marx Lecture - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Inactivation of TGF- signaling in CAR-T cells | Cellular & Molecular Immunology - Nature.com - February 29th, 2024 [February 29th, 2024]
- Babies use their immune system differently but efficiently | Cornell Chronicle - Cornell Chronicle - February 29th, 2024 [February 29th, 2024]
- Antibody reduces allergic reactions to multiple foods in NIH clinical trial - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]
- Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Theratechnologies announces publication in Frontiers in Immunology on TH1902 - TipRanks.com - TipRanks - February 21st, 2024 [February 21st, 2024]
- Smoking has long-term effects on the immune system - Institut Pasteur - February 21st, 2024 [February 21st, 2024]
- Spring Allergies Attack More Than Just Your Nose - ACAAI Public Website - American College of Allergy Asthma and Immunology - February 21st, 2024 [February 21st, 2024]
- Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Shikhar Mehrotra named co-leader of Cancer Biology and Immunology research program at MUSC Hollings - The Cancer Letter - January 27th, 2024 [January 27th, 2024]
- Gut Microbiome Benefits of Breast Milk Revealed in Mouse Study - Technology Networks - January 27th, 2024 [January 27th, 2024]
- Research on Immunological Diseases Launches with Hungarian Participation - Hungary Today - January 27th, 2024 [January 27th, 2024]
- UCLA to turn former shopping mall into centers for research on immunology and quantum science - The Associated Press - January 8th, 2024 [January 8th, 2024]
- TRexBio Announces a First Option Was Exercised by Partner under Immunology Discovery Collaboration - Business Wire - January 8th, 2024 [January 8th, 2024]
- UCLA to turn former Westside Pavilion into centers for research on immunology and quantum science - KABC-TV - January 8th, 2024 [January 8th, 2024]
- HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases - PR Newswire - January 8th, 2024 [January 8th, 2024]
- Beyond Cytotoxicity: The Importance of T Cell Memory - The Scientist - January 8th, 2024 [January 8th, 2024]
- IKAROS: Unlocking the secrets of the immune system's key player - News-Medical.Net - January 8th, 2024 [January 8th, 2024]
- UCLA to turn former shopping mall into centers for research on immunology and quantum science - The Caledonian-Record - January 8th, 2024 [January 8th, 2024]
- Revolutionizing Vaccine Research: The Power of a New Algorithm - SciTechDaily - December 31st, 2023 [December 31st, 2023]
- Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people ... - Nature.com - December 22nd, 2023 [December 22nd, 2023]
- Two new practice parameters offer recommendations for treating anaphylaxis and atopic dermatitis - News-Medical.Net - December 22nd, 2023 [December 22nd, 2023]
- Physician and Patient (Un)Wellness in Allergy and Immunology During COVID-19 and Beyond: Lessons for the Future - Physician's Weekly - December 22nd, 2023 [December 22nd, 2023]
- Researchers Identify Why Some Cancers Do Not Respond to Immunotherapy - NYU Langone Health - December 22nd, 2023 [December 22nd, 2023]
- MU's Haval Shirwan recognized for achievements in immunology - Columbia Daily Tribune - December 22nd, 2023 [December 22nd, 2023]